65,437 trials
Chest Pain · Coronary Artery Disease · Unstable Angina Pectoris
Primary: Total Mortality. — 138 Participants.
Type 2 Diabetes Mellitus
Primary: Change From Baseline in Hemoglobin A1c (HbA1c) at Week 24 — -0.43; -0.57 Percent
Infections, Streptococcal
Primary: Number of Subjects Reporting Grade 3 Symptoms (Solicited and Unsolicited) — 32; 36; 6; 14 subjects
Obesity
Primary: Knotting Elements Placed — 11 elements
Pain · Osteoarthritis
Primary: Pain Intensity Score as Measured by the 11-point Pain Intensity-Numerical Rating Scale Score at the End of the Study (Week 12 or Time of Discontinuation) — 4.3; 4.8…
Poliomyelitis · Acellular Pertussis · Tetanus
Primary: Number of Subjects With Anti-hepatitis B (HB) Antibody Concentrations Above the Cut-off One Month After the Booster Dose — 88; 92; 48 subjects
Tinnitus
Primary: Change in PET Asymmetry Index — 1.2 ratio
Pregnancy
Primary: Use of an Effective Method of Contraception at 6 Months After Requesting Emergency Contraception — 9; 13 participants
Allergy
Primary: Daily Rhinoconjunctivitis Symptom Score — 4.07; 4.14 Units on a scale (0-18) — p=0.87
Seasonal Allergic Rhinitis
Primary: Mean 24-hour Reflective Total 5 Symptoms Score (T5SS) — 8.96; 8.77 points on a scale — p=0.546
Hepatitis C, Chronic
Primary: Evaluation of the Satisfaction of the PegPen (PegIntron Preparation and Injection Easiness) Using a Patient Questionnaire Answered at 1 Month and 3 Months — 5.48; 5.91…
Arrhythmia · Atrial Fibrillation · Atrial Flutter
Primary: Relationship Between Amiodarone Concentration in Fat Tissue and Cumulated Dose. — 0.20 Correlation coefficient R
Rhinitis · Urticaria
Primary: Proportion of Patients With Adverse Events — 20; 4; 21; 6 participants
Diamond-Blackfan Anemia · Kostmann's Neutropenia · Shwachman-Diamond Syndrome
Primary: Number of Patients Alive (Survival) at 2 Years — 6 Participants
Carcinoma, Hepatocellular
Primary: Percentage of Participants for Each Type of Response — 0; 2.2; 5.8; 54.7 percentage of participants